journal article·2023-11

Topological Regulating Bismuth Nano‐Semiconductor for Immunogenic Cell Death‐Mediated Sonocatalytic Hyperthermia Therapy

Guobo Chen, Zhijin Yang, Jun Du, Zongyan He, Yule Zhang, Kejie Zheng, Shuqi Cai, Mengya Chen, Yuhao Li, Lulu Zheng, Yuqing Miao, Dawei Zhang

Small· Volume 19· Issue 48
Publisher page

Abstract

Abstract Immunogenic cell death (ICD) can activate the body's immune system via dead cell antigens to achieve immunotherapy. Currently, small molecule drugs have been used for ICD treatment in clinical, however, how to precisely control the induced ICD while treating tumors is of great significance for improving therapeutic efficacy. Based on this, a sono/light dual response strategy to tumor therapy and activation of ICD is proposed. A topological synthesis method is used to obtain sulfur‐doped bismuth oxide Bi2O3−xSx (BS) using BiF3 (BF) as a template through reduction and a morphology‐controllable bismuth‐based nano‐semiconductor with a narrow bandgap is constructed. Under the stimulation of ultrasound, BS can produce reactive oxygen species (ROS) through the sonocatalytic process, which cooperates with BS to consume glutathione and enhance cellular oxidative damage, further inducing ICD. Due to the introduction of sulfur in the reduction reaction, BS can achieve photothermal conversion under light, and combine with ROS to treat tumors. Further, with the assistance of ivermectin (IVM) to form composite (BSM), combined with sono/light dual strategy, ICD is promoted and DCs maturation is accelerated. The proposed ICD‐mediated hyperthermia/sonocatalytic therapy strategy will pay the way for synergetic enhancement of tumor treatment efficacy and provide a feasible idea for controllable induction of ICD.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Materials and Chemistry Institute of Bismuth Shanghai Collaborative Innovation Center of Energy Therapy for Tumors University of Shanghai for Science and Technology Shanghai 200093 China

Engineering Research Center of Optical Instrument and System the Ministry of Education & Shanghai Key Laboratory of Modern Optical System University of Shanghai for Science and Technology Shanghai 200093 China

Funding

Natural Science Foundation of Shanghai Municipality · National Key Research and Development Program of China · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
2. 10.1126/science.aaa817210.1126/science.aaa8172 ↗
3. 10.1200/JCO.21.0206710.1200/JCO.21.02067 ↗
4. 10.1016/j.ccell.2022.01.00210.1016/j.ccell.2022.01.002 ↗
5. 10.1038/s41551-019-0436-x10.1038/s41551-019-0436-x ↗
6. 10.1200/JCO.21.0180610.1200/JCO.21.01806 ↗
7. 10.1016/j.cell.2022.03.04110.1016/j.cell.2022.03.041 ↗
8. 10.1002/adma.20160603610.1002/adma.201606036 ↗
9. 10.1038/s41590-022-01132-210.1038/s41590-022-01132-2 ↗
10. 10.1002/advs.20220449810.1002/advs.202204498 ↗
11. 10.1038/s41419-020-03221-210.1038/s41419-020-03221-2 ↗
12. 10.1016/j.biomaterials.2022.12192010.1016/j.biomaterials.2022.121920 ↗
13. Kostopoulos I. V. · Am. J. Hematol. · 2022 · 98 · E65
14. 10.1080/2162402X.2020.179599510.1080/2162402X.2020.1795995 ↗
15. 10.1016/j.bbrc.2017.08.09710.1016/j.bbrc.2017.08.097 ↗
16. 10.1093/brain/awv16710.1093/brain/awv167 ↗
17. 10.1038/srep1622210.1038/srep16222 ↗
18. 10.15252/emmm.20140408410.15252/emmm.201404084 ↗
19. 10.1111/j.1476-5381.2012.01987.x10.1111/j.1476-5381.2012.01987.x ↗
20. 10.1002/adfm.20220081110.1002/adfm.202200811 ↗
21. 10.1002/advs.20170089110.1002/advs.201700891 ↗
22. 10.1002/adma.20220570110.1002/adma.202205701 ↗
23. 10.1002/smll.20180067810.1002/smll.201800678 ↗
24. 10.3389/fimmu.2021.70536110.3389/fimmu.2021.705361 ↗
25. 10.1002/smll.20220292110.1002/smll.202202921 ↗
26. 10.1002/adhm.20230023410.1002/adhm.202300234 ↗
27. 10.1039/D2BM01182D10.1039/D2BM01182D ↗
28. 10.1016/j.ccr.2023.21528110.1016/j.ccr.2023.215281 ↗
29. 10.1016/j.actbio.2022.12.06510.1016/j.actbio.2022.12.065 ↗
30. 10.1016/j.actbio.2021.05.01610.1016/j.actbio.2021.05.016 ↗
31. 10.1021/acsami.9b1364710.1021/acsami.9b13647 ↗
32. 10.1002/adma.20210683810.1002/adma.202106838 ↗
33. 10.1002/smll.20230032710.1002/smll.202300327 ↗
34. 10.1002/anie.20220948410.1002/anie.202209484 ↗
35. 10.1016/j.cej.2022.13638010.1016/j.cej.2022.136380 ↗
36. 10.1021/acsami.0c1885310.1021/acsami.0c18853 ↗
37. 10.1002/smll.20210455010.1002/smll.202104550 ↗
38. 10.1039/C8CS00649K10.1039/C8CS00649K ↗
39. 10.1016/j.cej.2019.12216110.1016/j.cej.2019.122161 ↗
40. 10.1016/j.solmat.2017.08.03310.1016/j.solmat.2017.08.033 ↗
41. 10.1021/acsanm.2c0015410.1021/acsanm.2c00154 ↗
42. 10.1039/C9NR06378A10.1039/C9NR06378A ↗
43. 10.1016/j.apcatb.2016.06.02010.1016/j.apcatb.2016.06.020 ↗
44. 10.1002/adhm.20210250310.1002/adhm.202102503 ↗
45. Pan M. · J. Cell. Physiol. · 2021 · 237 · 1245
46. 10.1007/s00280-020-04041-z10.1007/s00280-020-04041-z ↗
47. 10.1158/0008-5472.CAN-15-288710.1158/0008-5472.CAN-15-2887 ↗
48. 10.1016/j.biomaterials.2022.12179610.1016/j.biomaterials.2022.121796 ↗
49. 10.1021/acsami.0c0807410.1021/acsami.0c08074 ↗
50. 10.1016/j.oraloncology.2019.06.01610.1016/j.oraloncology.2019.06.016 ↗
51. 10.1002/smll.20200021410.1002/smll.202000214 ↗
52. 10.1038/nm162210.1038/nm1622 ↗
53. 10.1021/acsnano.1c0904810.1021/acsnano.1c09048 ↗
54. 10.1016/j.nano.2023.10266810.1016/j.nano.2023.102668 ↗
55. 10.1016/j.nantod.2023.10175910.1016/j.nantod.2023.101759 ↗
56. 10.1038/s41586-019-1836-510.1038/s41586-019-1836-5 ↗
57. 10.1158/1078-0432.CCR-21-359410.1158/1078-0432.CCR-21-3594 ↗